Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

November 22, 2018

Study Completion Date

February 14, 2019

Conditions
Hepatitis C Virus Infection
Interventions
DRUG

LDV/SOF

90/400 mg fixed- dose combination (FDC) tablet administered orally once daily

Trial Locations (21)

500

Changhua Christian Hospital, Changhua

1070

CUB Hopital Erasme, Brussels

1200

Cliniques Universitaires UCL Saint-Luc, Brussels

10002

National Taiwan University Hospital, Taipei

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino

10468

James J. Peters VA Hospital, The Bronx

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

20246

Universitatsklinikum Hamburg-Eppendorf (UKE), Zentrum fur Innere Medizin - Studienambulanz Hepatol., Hamburg

20251

Ifi Studien und Projekt GmbH an der Asklepios Klinik St. Georg, Hamburg

40447

China Medical University Hospital, Taichung

48202

Henry Ford Health System, Detroit

50011

Ospedale Santa Maria Annunziata, Antella

60590

Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt

71013

IRCCS Ospedale Casa Sollievo Della Sofferrenza, San Giovanni Rotondo

75203

The Liver Institute at Methodist Dallas Medical Center, Dallas

78215

Texas Liver Institute/American Research Corporation, San Antonio

80756

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

83301

Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

98104

University of Washington/Harborview Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

04103

Universitätsklinikum Leipzig, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT03036839 - Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease | Biotech Hunter | Biotech Hunter